Showing results (241-250 of 4,206) with videos related to

Sort By:
Pageof 421
Discover Oncology|May 2, 2023
ANXA6: a key molecular player in cancer progression and drug resistanceJinlong Cao, Shun Wan, Siyu Chen, et al.
Discover Oncology|May 10, 2023
Advances of exosomal miRNAs in the diagnosis and treatment of ovarian cancerJun Xiong, Fen Fu, Feng Yu, et al.
Discover Oncology|May 10, 2023
Targeting EFNA1 suppresses tumor progression via the cMYC-modulated cell cycle and autophagy in esophageal squamous cell carcinomaHouxiang Jiang, Shaoxiang Wang, Ying Liu, et al.
Discover Oncology|May 8, 2023
Prognostic factors and the necessity of chemotherapy for stage II gastric cancer: a model based on multicenter retrospective studyJiaming Fang, Feiyang Zhang, Jun Lu, et al.
Discover Oncology|May 22, 2023
The role of myeloid-derived suppressor cells in liver cancerShiyue Zhou, Zixuan Zhao, Hao Zhong, et al.
Discover Oncology|August 21, 2022
Construction of a breast cancer prognosis model based on alternative splicing and immune infiltrationDongni Zhang, Wenping Lu, Zhili Zhuo, et al.
Discover Oncology|August 12, 2022
Clinical factors associated with outcome in solid tumor patients treated with immune-checkpoint inhibitors: a single institution retrospective analysisQian Qin, Tomi Jun, Bo Wang, et al.
Discover Oncology|August 19, 2022
Combination of levofloxacin and cisplatin enhances anticancer efficacy via co-regulation of eight cancer-associated genesXiaoqiong He, Qian Yao, Dan Fan, et al.
Discover Oncology|November 10, 2022
The diagnostic accuracy of intraoperative differentiation and delineation techniques in brain tumoursLaura Van Hese, Steven De Vleeschouwer, Tom Theys, et al.
Discover Oncology|August 18, 2022
Lymph node ratio predicts overall survival in patients with stage II non-small cell lung cancer: a population-based SEER analysisNan Feng, Bo Wu, Xiang Zhang, et al.
Pageof 421